T1	Participants 66 107	adolescent HIV prevention trial in Kenya.
T2	Participants 185 222	adolescent sub-Saharan HIV prevention
T3	Participants 597 625	adolescent orphans in Kenya.
T4	Participants 643 760	837 Kenyan orphan youth in grades 7 and 8 enrolled in an HIV prevention clinical trial with HSV-2 biomarker outcomes.
T5	Participants 1061 1082	28 adolescents (3.3%)
T6	Participants 1154 1227	22 positive and all indeterminates were WB tested; 20 and 5, respectively
T7	Participants 1759 1782	adolescent participants
